Fortrea appoints William Sharbaugh as Class III director effective Sept 22, 2025

Fortrea Holdings Inc.

William Sharbaugh appointed to Fortrea Board as Class III director, effective Sept 22, 2025.
Sharbaugh served as COO of PPD, Inc. from 2007-2021 and held roles at Bristol-Myers Squibb and Merck.
No committee assignments yet; will receive standard non-employee director compensation per existing policy.
Sharbaugh currently chairs Ora LLC and serves on boards of Launch Therapeutics, Alcami, and BioCare.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.